Nanalyze

Nanalyze identifies four nuclear stocks via ETF overlap analysis, excluding pre-revenue SMRs.

15 min Listen to the original Episode page
Nuclear EnergyETF AnalysisSmall Modular ReactorsUranium MiningUtilities

Summary

Speaker_1 outlines a methodology of analyzing seven nuclear ETFs to identify common top holdings, finding BWXT as the only stock in the top 15 of all seven. The speaker critiques nuclear SPACs and pre-revenue Small Modular Reactor (SMR) companies like ACLA and TerraNova, citing past predictions of their decline and a policy against investing in companies with no revenues or market caps below $1 billion. Utility companies are evaluated for nuclear exposure, with Constellation Energy retained for its ~90% nuclear operations while others are dropped. The speaker proposes a 'mini nuclear ETF' consisting of BWXT, Cameco, Constellation Energy, and Centrus Energy to provide diversified exposure while avoiding ETF fees.

Key takeaways

  1. 1
    Speaker_1 suggests leveraging existing ETF compositions to identify high-conviction nuclear stocks, noting that BWXT was the only stock appearing in the top 15 holdings of all seven analyzed nuclear ETFs.

    Unidentified speaker (speaker_1) · 1:07

Episode sections

  1. 0:00 – 2:25

    Introduction and Methodology

    Speaker_0 introduces the topic of nuclear energy stocks driven by AI data center power demands. Speaker_1 outlines a methodology of analyzing seven nuclear ETFs to find common top holdings, identifying BWXT as the only stock in the top 15 of all seven ETFs.

  2. 2:25 – 4:59

    Critique of Nuclear SPACs and SMRs

    Speaker_1 criticizes nuclear SPACs and pre-revenue Small Modular Reactor (SMR) companies like ACLA, TerraNova, and Terrestrial Energy, citing past predictions of their decline. The speaker emphasizes a policy of not investing in companies with no revenues or market caps below $1 billion.

  3. 4:59 – 5:58

    Utility Exposure Analysis

    The speaker evaluates utility companies for nuclear exposure, noting Constellation Energy has ~90% nuclear operations, while PSEG and Duke have ~30%. Constellation is retained for its high exposure, while others are dropped for lacking majority nuclear revenue.

  4. 5:58 – 8:57

    GE Vernova and Uranium Producers

    GE Vernova is dismissed due to only 3% nuclear revenue. Kazatomprom is excluded for not trading on US exchanges. Cameco is preferred over Uranium Energy Corp due to higher production volume, cost efficiency, and a stake in Westinghouse.

  5. 8:57 – 11:56

    BWXT Deep Dive

    BWXT is analyzed as a top pick, with 70% government revenue and 30% commercial. The speaker highlights its acquisition of Connectrics, strong commercial growth, and a low SVR of 3.5 compared to its historical average of 5.

  6. 11:56 – 13:47

    Centrus Energy and HALU

    Centrus Energy is introduced as the only publicly traded producer of High-Assay Low-Enriched Uranium (HALU). The speaker notes its strategic importance for advanced reactors, strong balance sheet, and revenue visibility into 2040, despite current low revenue growth.

  7. 13:47 – 15:04

    Final Mini ETF Composition

    The speaker concludes by proposing a 'mini nuclear ETF' consisting of BWXT, Cameco, Constellation Energy, and Centrus Energy, arguing this provides diversified exposure while avoiding the fees of the VanEck ETF.

Assets discussed

AssetKindStanceContext
URANIUM ENERGY CORPUECequitybearishThe other two names here: Camico and Uranium Energy.

“Stance” is how the speakers talked about the asset, not a recommendation.

Claims worth verifying

Only one stock, BWXT, is found commonly across the top 15 names for all seven nuclear ETFs analyzed.

Unidentified speaker (speaker_1) ·1:26

How to verify: Check the holdings of the seven nuclear ETFs mentioned (likely including VanEck Nuclear ETF, Global X Uranium ETF, etc.) and compare their top 15 holdings to confirm BWXT's presence in all. For recent events, verify 2026-08-11 through 2026-11-11. Use another period only when the speaker explicitly names it.

Primary source

Constellation Energy has around 90% of its operations attributed to nuclear energy.

Unidentified speaker (speaker_1) ·5:18

How to verify: Review Constellation Energy's (CEG) latest 10-K or 10-Q filing with the SEC EDGAR database for segment reporting or operational breakdown. For recent events, verify 2026-08-11 through 2026-11-11. Use another period only when the speaker explicitly names it.

Primary source

PSEG and Duke have around 30% of their revenues coming from nuclear.

Unidentified speaker (speaker_1) ·5:39

How to verify: Review PSEG's (PEG) and Duke Energy's (DUK) latest 10-K or 10-Q filings with the SEC EDGAR database for revenue by segment. For recent events, verify 2026-08-11 through 2026-11-11. Use another period only when the speaker explicitly names it.

Primary source

GE Vernova has only about 3% of its revenues coming from nuclear.

Unidentified speaker (speaker_1) ·6:18

How to verify: Review GE Vernova's (GEV) latest 10-K or 10-Q filing with the SEC EDGAR database for revenue breakdown by business segment. For recent events, verify 2026-08-11 through 2026-11-11. Use another period only when the speaker explicitly names it.

Primary source

Cameco is the second-largest uranium supplier with 14% of all supply.

Unidentified speaker (speaker_1) ·7:38

How to verify: Consult the World Nuclear Association's 'Uranium: Resources, Production and Demand' report or Cameco's investor presentations for global production market share data. For recent events, verify 2026-08-11 through 2026-11-11. Use another period only when the speaker explicitly names it.

Westinghouse has 12 AP1000 reactors currently in operation and 19 in various stages of planning.

Unidentified speaker (speaker_1) ·8:18

How to verify: Review Westinghouse's official website or press releases regarding reactor construction status, or verify through nuclear regulatory bodies like the NRC. For recent events, verify 2026-08-11 through 2026-11-11. Use another period only when the speaker explicitly names it.

Westinghouse could file for an IPO as soon as October, according to Bloomberg.

Unidentified speaker (speaker_1) ·8:37

How to verify: Search Bloomberg News archives for articles from October 2026 regarding Westinghouse IPO filings. For recent events, verify 2026-08-11 through 2026-11-11. Use another period only when the speaker explicitly names it.

Primary source

BWXT returned 220% since 2019, while QQQ returned 338%.

Unidentified speaker (speaker_1) ·9:17

How to verify: Calculate the total return of BWXT stock from 2026 to the current date using a financial data provider like Yahoo Finance, and compare it to the QQQ ETF performance over the same period. For recent events, verify 2026-08-11 through 2026-11-11. Use another period only when the speaker explicitly names it.

Primary source

BWXT has 70% government revenue and 30% commercial revenue.

Unidentified speaker (speaker_1) ·9:39

How to verify: Review BWXT's latest 10-K or 10-Q filing with the SEC EDGAR database for revenue by customer type or segment. For recent events, verify 2026-08-11 through 2026-11-11. Use another period only when the speaker explicitly names it.

Primary source

Centrus Energy has $2 billion in cash and roughly $1 billion in long-term debt.

Unidentified speaker (speaker_2) ·13:15

How to verify: Review Centrus Energy's (LRN) latest 10-Q or 10-K filing with the SEC EDGAR database for the balance sheet. For recent events, verify 2026-08-11 through 2026-11-11. Use another period only when the speaker explicitly names it.

Primary source

Do your own research

  • Verify the top 15 holdings of the seven nuclear ETFs mentioned by Speaker_1 to confirm BWXT's presence.
  • Review the financial filings (10-K/10-Q) of ACLA, TerraNova, and Terrestrial Energy to assess current revenue status and market cap.
  • Check the latest quarterly reports for Constellation Energy, PSEG, and Duke Energy to verify the percentage of revenue derived from nuclear operations.
  • Confirm Cameco's current market share of global uranium supply and its stake in Westinghouse via company press releases or industry reports.
  • Analyze BWXT's recent earnings reports to validate the 70/30 government/commercial revenue split and the impact of the Connectrics acquisition.
  • Review Centrus Energy's backlog reports and contracts to verify the $3 billion HALU backlog and revenue visibility into 2040.
  • Assess the valuation assumptions behind the $50 billion Westinghouse IPO estimate mentioned by Speaker_1.
  • Check for any conflicts of interest or holdings disclosures from Speaker_1 regarding the four recommended stocks.
Full transcriptexpand
0:00
Unidentified speaker (UNKNOWN): Welcome
0:01
Unidentified speaker (speaker_0): to the Nanalize Podcast. We are a boutique media and research firm specializing in disruptive innovation. Visit Nanalize.com for more details.
0:15
Unidentified speaker (speaker_0): Nuclear is the hottest trade in energy right now. AI data centers need massive amounts of power that never switches off. Tech giants are signing deals to start old reactors. And
0:27
Unidentified speaker (speaker_1): some tiny reactor companies with no revenues are worth billions of dollars. When a stock goes up that much on a story, investors are going to get burned. In this video, we're gonna cut through all the hype and tell you the best nuclear stocks to invest in. No science projects with a ticker symbol. Real companies with real revenues. And the first step
0:47
Unidentified speaker (speaker_1): to finding a universe of nuclear stocks is to use the most valuable lesson I learned while achieving MBA. Always leverage the hard work of others and shamelessly take credit for it. Seven firms out there decided to create nuclear ETFs, so we're gonna see what names they could all agree upon. These are experts who spent
1:07
Unidentified speaker (speaker_1): a lot of time figuring out the right stocks to include in their ETFs. They've done all the work. So a simple question: if we took the top 15 names from each of these seven ETFs, which names would we find they all had in common? Turns out only one stock can be found commonly across the top
1:26
Unidentified speaker (speaker_1): 15 names for all seven of these ETFs. That's BWXT. An additional three stocks can be found in six of the seven ETFs, and then five stocks in at least four of the seven ETFs. That gives us nine names to work with, so let's make it a nice round ten. Today's theme
1:46
Unidentified speaker (speaker_1): is exposure, not the Chernobyl type of exposure where a little goes a long way. You know, my mate visited Chernobyl recently, gave it four thumbs up. First thing to do here is look at these ETFs a bit more. For example, we can see how much weighting these top names are given across all seven ETFs. The
2:06
Unidentified speaker (speaker_1): highest concentration seems to be in the lowest fee ETF, which also has the highest AUM. So if you were going to invest in one of these nuclear ETFs, I think that would be probably the best one. The Vannec Nuclear and Uranium ETF. So let's start by going through these nuclear stocks, starting with these
2:25
Unidentified speaker (speaker_1): SPACs. Nuclear SPACs are like Chernobyl. They melt down fast and could leave your portfolio glowing red for decades. Last year we specifically warned about how overheated ACLA was becoming. We also said other nuclear SPACs were going to run into problems as well. Piece here titled
2:45
Unidentified speaker (speaker_1): You see The Hidden Flaw Dooming ACLO OClo and Nuclear Stocks in 2026. Now many people had a bone to pick with our findings. Mainly, they didn't like the fact that we suggested these stocks were being hyped. Here's one of many comments. This one confuses the quality of the thesis with the quality of the investment
3:05
Unidentified speaker (speaker_1): opportunities, says this person. He is thinking about the now, as he always does. Instead, not understand the dire need for energy clean energy. Mongo no like, think now. Nanalize, please stop being obsessed with revenue. Improve your ability to project. Well, we worked on that and we've
3:24
Unidentified speaker (speaker_1): improved our ability to project. Here you can see where we projected the decline of these nuclear spACs. We'll go down the list here. New scale losing 80%, Occlo losing 75%, Terra Innovatum 66%.
3:39
Unidentified speaker (speaker_1): down, and terrestrial energy down 79%. Put that into perspective, if you're 80% down, it's gonna take about a 400% price appreciation to work your way back out of that hole. Now another commenter said, Well, ISMR is different. It's terrestrial energy. How exactly? It's a pre-revenue spec,
3:59
Unidentified speaker (speaker_1): we asked. No answer. Well, it wasn't different as it turns out. Big question to ask here, of course, is there value to be had in these SMR stocks at the presumably deflated valuations they sit today? Well, it's very tough to gauge valuation without any fundamentals at all, right? So, first of all, we
4:19
Unidentified speaker (speaker_1): don't invest pre-revenue and we don't invest below a $1 billion market cap. So, for these companies, what's going to happen if this easy capital dries up, right? And over time, other names have emerged as well. You have X Energy, which actually did a proper IPO, but it comes down to this, as always: no
4:39
Unidentified speaker (speaker_1): revenues, no interest, no exceptions. So the two SMR companies on our list are going to the bottom of our ranking here, Occlo and New Scale. So we have eight names remaining. Three of these are utility companies. As I said, it's very important to look at exposure for any nuclear stock you're
4:59
Unidentified speaker (speaker_1): investing in, right? Exposure is what you want here. Otherwise you're not investing in nuclear, right? And dominant providers are likely to be experts in their space and thrive, right? Leaders are what we look for. But remember, even at 100% exposure, a utility is
5:18
Unidentified speaker (speaker_1): not really the kind of pick and shovel play we're looking for ideally. Nonetheless, we look through these names, we see that constellation, around 90% of their operations can be attributed to nuclear energy. Then you have PSEG and Duke, both with around 30% of their revenues coming from nuclear.
5:39
Unidentified speaker (speaker_1): We usually look for a majority before even considering exposure in something to be meaningful. So these we would drop off the list, whilst Constellation would be compelling for the fact that they run such a large fleet of nuclear reactors. So now we have five stocks left to vet. GE Vernova looks quite
5:58
Unidentified speaker (speaker_1): familiar because they're one of the four stocks in our mini ETF. for the electrification thesis. Now, only about 3% of the revenues come from nuclear, so there's no real sense in holding that because you're not getting the exposure you're looking for. Sure, the rest of the exposure may be compelling, but we're looking for
6:18
Unidentified speaker (speaker_1): nuclear exposure. Now, there's somewhat of a two birds with one stone play here because GE Vernova is also building SMI. SMRs, but they're quite a ways down the road. They talk about value creation in the 2030s. So without that exposure, it's not a highly ranked nuclear stock. It may be a good
6:38
Unidentified speaker (speaker_1): stock, but it's not a highly ranked nuclear stock. We now have four names left. Three of these remaining names are uranium plays, uranium being the fuel of nuclear reactors. Now we're dropping. Kazatom Prom because they don't trade in the United States. We're gonna try to come up with a little mini ETF as part of this
6:58
Unidentified speaker (speaker_1): exercise, and I think every constituent ought to be available on a U.S. exchange. Sure, they're the largest producer of uranium. That's compelling, but there's a better way to play this without the country risk. The other two names here: Camico and Uranium Energy. Now you look at a quick comparison of these
7:18
Unidentified speaker (speaker_1): two companies in terms of size, revenues, the actual uranium they're producing, what they're able to produce it at, their costs, right? And it's clear that Camico comes ahead here. And we actually covered them late last year in this piece on uranium stocks. When we look at 2025 uranium supply by
7:38
Unidentified speaker (speaker_1): producer, we see they're in second place there with 14% of all supply. They're the second largest uranium supplier. And about a year ago, as I said, we highlighted this company and noted their investment in Westinghouse. Westinghouse built the world's first commercial pressurized water reactor. Today, 430 nuclear
7:57
Unidentified speaker (speaker_1): reactors operate around the world using Westinghouse technology. They've performed more than 150 plant upgradings. So that basically is the equivalent of adding five new reactors just by improving infrastructure we already have. Now there are flagship AP 1000 reactors. They have 12 of those currently in operation,
8:18
Unidentified speaker (speaker_1): a further 19 in various stages of planning. Now, some interesting news that came out recently. Apparently, Westinghouse could file for an IPO as soon as October, Bloomberg has reported. So that would be this month. Hasn't happened yet. And they talk about this identified pipeline of 50 reactors. Well, an identified
8:37
Unidentified speaker (speaker_1): pipeline in five bucks might get you a cup of coffee at Starbucks, right? That means very little. And Bloomberg goes on to say that this $50 billion Dollar plus valuation they want to command would partly depend on investors assigning value today. to projects that could stretch well into the 2030s. Nonetheless, Chemical remains a compelling way to
8:57
Unidentified speaker (speaker_1): get nuclear exposure for any number of reasons. Now we're left with BWXT, which we covered way back in 2019, long before nuclear started getting hyped in this piece, invest in nuclear energy with this one stock. Now, since then it's returned 220%. Now, lots of folks would leave it at that, but
9:17
Unidentified speaker (speaker_1): in order to gauge that return, you need a benchmark. We look at QQQ, that returned 338%. So investing in that company wouldn't have been a good idea. Now, back then we noted that 75% of the revenues were reliant on the government and that was going to change. Well, seven years
9:37
Unidentified speaker (speaker_1): later, we're at 70%.
9:39
Unidentified speaker (speaker_1): government, 30% commercial, a good chunk, almost half the revenues coming from naval nuclear. So a couple things to point out here. First of all, they have really been growing strong. You see here 19% growth expected for this year. Well, that's due to the growth in commercial because government really isn't
9:59
Unidentified speaker (speaker_1): growing very much. And this acquisition of connectrics. connectrix that added about 39 points of the 72 points of revenue growth they saw from commercial, it's actually not that richly valued right now with an SVR of 3.5. That's compared to its historical SVR of five, and also our catalog average of around
10:19
Unidentified speaker (speaker_1): eight. Now, the story here is that they're going to start growing commercial a lot more, and you can see this time. timeline here where they've made a number of acquisitions, this precision components group, and of course connectrics. Here you can see the breakdown of what their commercial operations look like. So services and
10:39
Unidentified speaker (speaker_1): components, those are pretty good, right? Because you can keep supplying those over time. They're sort of like recurring revenues. Medical, I believe they're going to spin that segment off, but this slide. in their recent investor deck, you can take a look at it, was just put out last month. This talks about the growth of commercial over time. And presumably they
10:59
Unidentified speaker (speaker_1): want this to reduce their reliance on government, as we do as well. Now, there are admittedly some build-its and they will come elements to this BWXT story. They really seem inherent to this entire nuclear build-out, right? Do you make all these investments early? on, and then later on in the 2030s, all the profits start pouring
11:19
Unidentified speaker (speaker_1): in. With BWXT, I think you need to believe that they're eventually going to remove that strong reliance on naval reactors. Though it isn't necessarily a bad thing because those aren't really going away. This is not nearly as bad as the pre-revenue spec SPAC stories being spun, we'll put it that way. So that leaves us with. really
11:39
Unidentified speaker (speaker_1): three stocks that we'd consider building a mini nuclear ETF around. That would be BWXT, Camiko, and Constellation Energy. However, we're not done yet. So one of our most popular videos was on a nuclear stock that everyone seems to be missing.
11:56
Unidentified speaker (speaker_2): Centris Centrus Energy is the only publicly traded enricher of high high-assay, assay, low low-enriched enriched uranium or Haliu. Heliu is required by most advanced nuclear reactors as well as nuclear propulsion rockets. It's made by sending uranium isotopes through centrifuges. Now, an isotope is simply a type of atom, and a centrifuge is a device used
12:16
Unidentified speaker (speaker_2): for separating substances of different densities. It spins the substances, creating a centrifugal force, and the substances with greater densities will move towards the outside. That's how Centris is able to create Haliw, or uranium with higher percentages of U235. It's also where the company gets its name, Centrus. Heliu promises less
12:36
Unidentified speaker (speaker_2): waste, longer lifespan, and greater efficiency than traditional uranium. And Centris's AC100 centrifuge design is the only deployment-ready Employment ready enrichment technology capable of unobligated enrichment, which means it's the only one that can be used. for US national security missions. The problem? It's not commercially available yet. The
12:56
Unidentified speaker (speaker_2): company is working on expanding capacity to meet that future demand, but they're only expecting $475 million in revenue this year, which would be the second year in a row of lackluster single digit growth. In the meantime, investors can watch Centrus' $3 billion HALU HALYU Backlog, which is dependent on this ongoing build build-out out that's being funded right now by. the National Nuclear
13:15
Unidentified speaker (speaker_2): Security Administration, foreign investors, and future prospective customers. Financially, Centrus has a strong cash position, $2 billion in cash with roughly $1 billion in long-term debt, and they're currently profitable on a net income basis. They claim they have revenue visibility into 2040 based on contracts that they currently have. And along with the strong balance sheet, this
13:35
Unidentified speaker (speaker_2): gives the company a bit of stability while we wait for that Hallyu Halio revenue. to generate sometime by the end of the decade. The company appears to be a good strategic, if not risky, addition to our mini ETF.
13:47
Unidentified speaker (UNKNOWN): Our
13:47
Unidentified speaker (speaker_1): mini nuclear ETF seems to contain a nice mix of names. You have BWXT, which is a pure play with seemingly not optional government exposure and an emerging commercial segment. You have Camiko Camico and their interesting stake in Westinghouse. You have Constellation Energy with some near pure play nuclear
14:08
Unidentified speaker (speaker_1): utility exposure. And finally, you could add Centris Energy, which produces a fuel that a majority of advanced reactor concepts need, HALIU. These four companies make for a nice little mini nuclear ETF so you can avoid paying Van Eck 52 basis points. Now earlier I mentioned GE Vernova as part of a mini
14:27
Unidentified speaker (speaker_1): ETF we put together for the electrification thesis. Thanks for taking the time.
14:34
Unidentified speaker (UNKNOWN): Thank
14:35
Unidentified speaker (speaker_0): you for listening to the Nanalize Podcast. If you found this information useful, please share this episode with a friend. This helps us to continue to provide thorough research for you. Want more research like this? Want to know what we're invested in and what stocks we're avoiding? Head to Nanalize.com. and consider becoming a premium annual subscriber to get access to
14:54
Unidentified speaker (speaker_0): premium articles, webinars, and our extensive tech stock catalog. Thank you for your
15:00
Unidentified speaker (UNKNOWN): time.
This page was produced automatically: the audio was transcribed with nvidia/parakeet-tdt-0.6b-v3+sortformer-v2.1 and interpreted by Qwen3.6-35B-A3B-UD-IQ3_S.gguf. Transcription and interpretation can contain errors; always confirm against the original episode. Nothing here is investment advice.

More from Nanalyze

Nanalyze

Which Big AI Company Goes Bankrupt First?

Episode discussion: Speakers analyze AI sector bankruptcy risks using CDS data and reflexive financing models

Speakers’ claims: Speaker 1 introduces the topic of identifying the first AI company to go bankrupt, citing recent market volatility and concerns over circular financing. The speaker explains how credit default swaps (CDS) measure risk, calculating a 60% implied default probability for CoreWeave over five years. Speaker 1 argues NeoClouds are more vulnerable than hyperscalers due to negative operating cash flows, while Speaker 3 discusses NVIDIA's 'reflexive' financing model tied to customer performance. Finally, the speaker cites Polymarket data showing a 27% chance of an AI bubble bursting before June 2027 based on specific adverse events.

AI InfrastructureCredit Default SwapsNVIDIA
14 min6 assets10 claims to verify
Nanalyze

It's Boring, But It Pays 15% Guaranteed for Life

Episode discussion: Speakers argue 15% guaranteed annuities are inferior to 60-40 portfolios due to inflation, opportunity cost, and lack of liquidity.

Speakers’ claims: Speaker 1 introduces a hypothetical New York Life annuity offering a 15% nominal return but argues it is misleading due to inflation and opportunity cost. Speaker 2 compares this to a 60-40 stock-bond portfolio, demonstrating that the portfolio preserves principal and offers higher cumulative value even in poor market scenarios. Speakers warn that annuity issuers profit from mortality risk and high commissions, advising against allocating more than 10% of assets to a single issuer. The episode concludes that asset allocation is a superior solution to sequence of returns risk compared to annuities.

AnnuitiesAsset AllocationRetirement Planning
15 min0 assets6 claims to verify
All insights